Skip to content
2000
Volume 15, Issue 2
  • ISSN: 1871-5222
  • E-ISSN: 1875-6115

Abstract

Azidothymidine (AZT) was the first breakthrough drug developed for the treatment of acquired immunodeficiency syndrome (AIDS). It took AZT only 25 months from the first successful laboratory activity against human immunodeficiency virus (HIV) to its approval by the FDA. Similar interesting facts and disputes have persistently been associated with AZT starting from its very first synthesis to the development and approval as drug. This review briefly collates the exciting history of AZT and, as the different stages involved in the discovery and the development of this drug molecule gets recapitulated here, could well serve as a mnemonic for the area of drug discovery and development in general.

Loading

Article metrics loading...

/content/journals/iemamc/10.2174/1871522215666150910205246
2015-08-01
2025-10-06
Loading full text...

Full text loading...

/content/journals/iemamc/10.2174/1871522215666150910205246
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test